FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mckesson Medical-Surgical Inc. Corporate Office Asthmanefrin Racephinephrine Inhalation Recall

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief o…

Mckesson Medical-Surgical Inc. Corporate Office · Richmond, VA

Risk level
Class II
Reported by FDA
Aug 17, 2022
Recall ID
D-1324-2022
Check your lot numberHow we source this data

Summary

Mckesson Medical-Surgical Inc. Corporate Office recalled Asthmanefrin Racephinephrine Inhalation starting Jun 29, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1324-2022 on Aug 17, 2022. Reason: CGMP Deviations: products were stored outside the drug label specifications. Status: Terminated.

Why it was recalled

CGMP Deviations: products were stored outside the drug label specifications.

Product description

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

Lot numbers, UPCs & expiration codes

No codes were listed in the FDA report.

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1324-2022
Classification
Class II
Status
Terminated
Recall initiated
Jun 29, 2022
FDA report date
Aug 17, 2022
Quantity
1 box
Recall type
Voluntary: Firm initiated
Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office

Original FDA data

Every field from FDA enforcement report D-1324-2022, exactly as published.

Show all FDA fields
City
Richmond
State
VA
Status
Terminated
Country
United States
Event ID
90553
Address
9954 Maryland Drive
Address (line 2)
Deep Run Iii Ste. 4000
Postal code
23233
Report date
Aug 17, 2022
Product type
Drugs
Recall number
D-1324-2022
Classification
Class II
Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
Product quantity
1 box
Termination date
Feb 13, 2024
Reason for recall
CGMP Deviations: products were stored outside the drug label specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Jun 29, 2022
Initial firm notification
Letter
Center classification date
Aug 5, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1324-2022, published Aug 17, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls